Providence Therapeutics Holdings Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie To Pay $48m Up Front For Preclin

China's biotechs are stepping up efforts to develop messenger RNA COVID-19 vaccines that target the Omicron variant, especially as a booster shot, given that 31% of fully-vaccinated people in the coun

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Juniper Acquires Kolon’s Cell-Mediated

Bill Gates is backing efforts to get Indian partners into the equation for new platforms like mRNA, which the multi-billionaire co-founder of Microsoft expects will not only ensure huge scale for vacc